Immunoclin (Immunoclin) COGS-to-Revenue : 0.00 (As of Oct. 2014)

View and export this data going back to 2012. Start your Free Trial

What is Immunoclin COGS-to-Revenue?

Immunoclin's Cost of Goods Sold for the three months ended in Oct. 2014 was $0.00 Mil. Its Revenue for the three months ended in Oct. 2014 was $0.01 Mil.

Immunoclin's COGS to Revenue for the three months ended in Oct. 2014 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Immunoclin's Gross Margin % for the three months ended in Oct. 2014 was N/A%.

Immunoclin COGS-to-Revenue Historical Data

The historical data trend for Immunoclin's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunoclin COGS-to-Revenue Chart

Immunoclin Annual Data

Trend

Feb12

Jan13

Jan14

COGS-to-Revenue

Immunoclin Quarterly Data
	May11	Aug11	Nov11	Feb12	May12	Aug12	Nov12	Feb13	May13	Aug13	Nov13	Apr14	Jul14	Oct14
COGS-to-Revenue	Get a 7-Day Free Trial									-	-	-	-	-

Immunoclin COGS-to-Revenue Calculation

Immunoclin's COGS to Revenue for the fiscal year that ended in Jan. 2014 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Immunoclin's COGS to Revenue for the quarter that ended in Oct. 2014 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0.005
	=	0.00

Immunoclin (GREY:IMCL) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Immunoclin's Gross Margin % for the three months ended in Oct. 2014 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 0.005
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Immunoclin COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Immunoclin's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Immunoclin (Immunoclin) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunoclin Corp (GREY:IMCL) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

9107 Wilshire Boulevard, Suite 450, Beverly Hills, CA, USA, 90210

Website

http://www.immunoclin.com

Immunoclin Corp is engaged in immunology research and development skill to serve the pharmaceutical, biotechnology and food industries, providing comprehensive, clinical and basic science research expertise at a commercial scale and quality.

Immunoclin (Immunoclin) Headlines

No Headlines